China Green Agriculture, Inc. (CGA) Analysts See $0.14 EPS; Profile of 3 Analysts Covering Collagen Solutions plc (LON:COS)

January 14, 2018 - By Louis Casey

Analysts expect China Green Agriculture, Inc. (NYSE:CGA) to report $0.14 EPS on February, 13.They anticipate $0.01 EPS change or 6.67% from last quarter’s $0.15 EPS. CGA’s profit would be $5.40M giving it 2.68 P/E if the $0.14 EPS is correct. After having $0.13 EPS previously, China Green Agriculture, Inc.’s analysts see 7.69% EPS growth. The stock decreased 1.96% or $0.03 during the last trading session, reaching $1.5. About 116,819 shares traded. China Green Agriculture, Inc. (NYSE:CGA) has risen 2.44% since January 14, 2017 and is uptrending. It has underperformed by 14.26% the S&P500.

Among 3 analysts covering Collagen Solutions (LON:COS), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Collagen Solutions had 8 analyst reports since September 16, 2015 according to SRatingsIntel. The stock of Collagen Solutions plc (LON:COS) has “Buy” rating given on Monday, July 11 by Panmure Gordon. The rating was maintained by Panmure Gordon with “Buy” on Wednesday, November 18. The firm earned “Speculative Buy” rating on Tuesday, December 20 by Beaufort Securities. Panmure Gordon maintained the stock with “Buy” rating in Wednesday, September 16 report. The firm earned “Buy” rating on Thursday, September 15 by Panmure Gordon. Beaufort Securities maintained the stock with “Buy” rating in Tuesday, July 12 report. The firm earned “Buy” rating on Thursday, October 13 by Panmure Gordon. Cenkos maintained the stock with “Buy” rating in Tuesday, July 11 report. See Collagen Solutions plc (LON:COS) latest ratings:

China Green Agriculture, Inc., through its subsidiaries, engages in the research, development, production, and sale of various types of fertilizers and agricultural products. The company has market cap of $57.83 million. The firm operates in three divisions: Jinong, Gufeng, and Yuxing. It has a 2.54 P/E ratio. The Company’s fertilizer products include humic acid compound fertilizers, compound fertilizers, blended fertilizers, organic compound fertilizers, slow-release fertilizers, water-soluble fertilizers, and mixed organic-inorganic compound fertilizers.

Collagen Solutions plc develops, manufactures, and supplies medical grade collagen components and biomaterials for use in regenerative medicines, medical devices, and in-vitro diagnostics in Europe, the Middle East, Africa, North America, and Asia. The company has market cap of 8.92 million GBP. It offers collagen solubles, powders, fibrillars, gels, sheets, sponges, matrices, and other products for use in tissue matrices for medical and surgical support devices, including dental, orthopedic, hemostatic, and other applications; Bovine Pericardium is used in bio-prosthetic heart valves, dural closures, bone and dental membranes, and surgical buttressing applications; and BSE-free bovine biomaterials. It currently has negative earnings. The firm also provides product development and contract manufacturing services for collagen products.

It closed at GBX 2.75 lastly. It is down 0.00% since January 14, 2017 and is . It has underperformed by 16.70% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>